SCHEMBL25834709

SCHEMBL25834709

COc1ccccc1C1=CC(=O)[C@@H](O)[C@@H](O)C1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.44
PTPRC P08575 1/20 0.42
PTPN1 P18031 1/20 0.42
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
CYP19A1 P11511 1/20 0.40
ACHE P22303 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
GAA P10253 2/20 0.39
PDK2 Q15119 1/20 0.39
RAB9A P51151 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PTGS2 P35354 1/20 0.39
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 4/20 0.39
TDP1 Q9NUW8 2/20 0.39
APP P05067 1/20 0.39
USP2 O75604 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25835384 1.00 L3MBTL1 (0.44) L3MBTL1PTPRCPTPN1HSP90AA1HSP90AB1
SCHEMBL25834382 0.88 L3MBTL1 (0.43) L3MBTL1PTPRCPTPN1HSP90AA1HSP90AB1
SCHEMBL25835385 0.76 L3MBTL1 (0.46) L3MBTL1PTPRCPTPN1CYP19A1ACHE
SCHEMBL25834695 0.71 BACE1 (0.53) PTPN1MEN1KMT2ARAB9APTGS2
SCHEMBL25834603 0.71 BACE1 (0.42) L3MBTL1PTPRCPTPN1MEN1KMT2A
SCHEMBL25837763 0.70 HDAC4 (0.48) HSP90AA1HSP90AB1MEN1KMT2AGAA
SCHEMBL25834322 0.68 MAPT (0.53) L3MBTL1PTPRCPTPN1MEN1KMT2A
SCHEMBL28483481 0.68 L3MBTL1 (0.50) L3MBTL1PTPRCPTPN1MEN1KMT2A
SCHEMBL29475765 0.67 CYP19A1 (0.47) L3MBTL1PTPRCPTPN1CYP19A1ACHE
SCHEMBL29429633 0.66 CA1 (0.71) L3MBTL1MEN1KMT2AGAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227393-A1 IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES THE UNIVERSITY OF HONG KONG (CN) 2023-07-20 US disclosed
US-20230227393-A1 IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES THE UNIVERSITY OF HONG KONG (CN) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227393-A1 IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES NFE2L2, DUOX1, DUOX2 L3MBTL1 4202/4885PTPRC 3535/4885PTPN1 4633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.